Anti-estrogens for early breast cancer - tamoxifen or aromatase inhibitor (AI) and for how long? 10-year update on ATLAS/aTTom

Richard Gray; Robert Hills; Laila Shah; Rebecca Stowe; R Davies

Anti-estrogens for early breast cancer - tamoxifen or aromatase inhibitor (AI) and for how long? 10-year update on ATLAS/aTTom

Richard Gray, Robert Hills, Laila Shah, Rebecca Stowe, R Davies

Research output: Contribution to conference (unpublished) › Abstract

Original language	English
Pages	128-129
Number of pages	2
Publication status	Published - 1 Jan 2006
Event	Endocrine Treatment and Prevention of Breast and Gynaecological Cancers. 5th Biennial International Meeting of the Flemish Gynaecological Oncology Group (FGOG) - Duration: 1 Jan 2006 → …

Conference

Conference	Endocrine Treatment and Prevention of Breast and Gynaecological Cancers. 5th Biennial International Meeting of the Flemish Gynaecological Oncology Group (FGOG)
Period	1/01/06 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Gray, R., Hills, R., Shah, L., Stowe, R., & Davies, R. (2006). Anti-estrogens for early breast cancer - tamoxifen or aromatase inhibitor (AI) and for how long? 10-year update on ATLAS/aTTom. 128-129. Abstract from Endocrine Treatment and Prevention of Breast and Gynaecological Cancers. 5th Biennial International Meeting of the Flemish Gynaecological Oncology Group (FGOG).

@conference{dd175242ac924bad892157976303413a,

title = "Anti-estrogens for early breast cancer - tamoxifen or aromatase inhibitor (AI) and for how long? 10-year update on ATLAS/aTTom",

author = "Richard Gray and Robert Hills and Laila Shah and Rebecca Stowe and R Davies",

year = "2006",

month = jan,

day = "1",

language = "English",

pages = "128--129",

note = "Endocrine Treatment and Prevention of Breast and Gynaecological Cancers. 5th Biennial International Meeting of the Flemish Gynaecological Oncology Group (FGOG) ; Conference date: 01-01-2006",

}

Anti-estrogens for early breast cancer - tamoxifen or aromatase inhibitor (AI) and for how long? 10-year update on ATLAS/aTTom. / Gray, Richard; Hills, Robert; Shah, Laila et al.
2006. 128-129 Abstract from Endocrine Treatment and Prevention of Breast and Gynaecological Cancers. 5th Biennial International Meeting of the Flemish Gynaecological Oncology Group (FGOG).

Research output: Contribution to conference (unpublished) › Abstract

TY - CONF

T1 - Anti-estrogens for early breast cancer - tamoxifen or aromatase inhibitor (AI) and for how long? 10-year update on ATLAS/aTTom

AU - Gray, Richard

AU - Hills, Robert

AU - Shah, Laila

AU - Stowe, Rebecca

AU - Davies, R

PY - 2006/1/1

Y1 - 2006/1/1

M3 - Abstract

SP - 128

EP - 129

T2 - Endocrine Treatment and Prevention of Breast and Gynaecological Cancers. 5th Biennial International Meeting of the Flemish Gynaecological Oncology Group (FGOG)

Y2 - 1 January 2006

ER -